EG20202A - Benzopyran and related LTB4 antagonists - Google Patents

Benzopyran and related LTB4 antagonists

Info

Publication number
EG20202A
EG20202A EG3293A EG3293A EG20202A EG 20202 A EG20202 A EG 20202A EG 3293 A EG3293 A EG 3293A EG 3293 A EG3293 A EG 3293A EG 20202 A EG20202 A EG 20202A
Authority
EG
Egypt
Prior art keywords
benzopyran
ltb4 antagonists
related ltb4
antagonists
ltb4
Prior art date
Application number
EG3293A
Other languages
English (en)
Inventor
Kevin Koch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG20202A publication Critical patent/EG20202A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
EG3293A 1992-01-23 1993-01-02 Benzopyran and related LTB4 antagonists EG20202A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82441292A 1992-01-23 1992-01-23

Publications (1)

Publication Number Publication Date
EG20202A true EG20202A (en) 1997-10-30

Family

ID=25241346

Family Applications (1)

Application Number Title Priority Date Filing Date
EG3293A EG20202A (en) 1992-01-23 1993-01-02 Benzopyran and related LTB4 antagonists

Country Status (36)

Country Link
US (2) US5552435A (cs)
EP (1) EP0623123B1 (cs)
JP (1) JP2765757B2 (cs)
KR (2) KR0124802B1 (cs)
CN (1) CN1041311C (cs)
AP (1) AP352A (cs)
AT (1) ATE152108T1 (cs)
AU (1) AU666896B2 (cs)
BG (1) BG62331B1 (cs)
BR (1) BR9207061A (cs)
CA (1) CA2126752C (cs)
CZ (1) CZ282400B6 (cs)
DE (1) DE69219364T2 (cs)
DK (1) DK0623123T3 (cs)
EG (1) EG20202A (cs)
FI (1) FI943474A0 (cs)
GR (1) GR3023657T3 (cs)
HU (1) HU221194B1 (cs)
IL (1) IL104386A (cs)
IS (1) IS1795B (cs)
MX (1) MX9300312A (cs)
MY (1) MY109144A (cs)
NO (1) NO306508B1 (cs)
NZ (1) NZ245735A (cs)
OA (1) OA11456A (cs)
PH (1) PH30346A (cs)
PL (1) PL171003B1 (cs)
PT (1) PT101183B (cs)
RO (1) RO112031B1 (cs)
RU (1) RU2114110C1 (cs)
SG (1) SG49813A1 (cs)
SK (1) SK280451B6 (cs)
TW (1) TW213907B (cs)
WO (1) WO1993015067A1 (cs)
YU (1) YU48949B (cs)
ZA (1) ZA93486B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2084547B1 (es) * 1993-07-12 1997-01-16 Pfizer Antagonistas benzopiranicos y relacionados de leucotrieno b4.
KR100232340B1 (ko) * 1994-10-13 1999-12-01 디. 제이. 우드, 스피겔 알렌 제이 류코트리엔 b4(ltb4) 길항물질로서의 벤조피란 및 벤조-축합된 화합물
EP0785930A1 (en) * 1994-10-13 1997-07-30 Pfizer Inc. Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b 4? (ltb 4?) antagonists
DK0925292T3 (da) * 1996-09-16 2004-01-12 Pfizer Fremgangsmåder og mellemprodukter til fremstilling af substituerede chromanolderivater
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
IL121931A (en) * 1996-10-17 2000-02-17 Pfizer Pharmaceutical compositions for preventing allograft rejection
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection
US6436987B1 (en) * 2000-06-08 2002-08-20 Pfizer Inc. Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid
WO2002036173A2 (en) 2000-11-03 2002-05-10 Bristol-Myers Squibb Pharma Company Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
CA2433516A1 (en) * 2001-01-30 2002-08-08 Keith Michael Devries Processes for preparing chromanylbenzoic acids
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
JP2008506768A (ja) * 2004-07-22 2008-03-06 ファルマシア コーポレーション Cox−2選択的阻害剤とltb4受容体アンタゴニストを組み合わせて用いる炎症および疼痛を治療するための組成物
WO2017095724A1 (en) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
US10450309B2 (en) 2015-11-30 2019-10-22 Merch Sharp & Dohme Corp. Aryl sulfonamides as BLT1 antagonists
US10336733B2 (en) 2015-11-30 2019-07-02 Merk Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
WO2017095723A1 (en) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2309282A1 (de) * 1973-02-24 1974-08-29 Hoechst Ag Verfahren zur herstellung von 4-hydroxy-thiochromanen
DE2745305A1 (de) * 1977-10-07 1979-04-19 Bayer Ag Insektizide und akarizide mittel
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (en) * 1987-01-12 1993-07-20 Darrel M. Gapinski Anti-inflammatory agents
JPS63292977A (ja) * 1987-05-25 1988-11-30 片山 晋 スキ−用のビンディング固定板
MX13485A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
FI914683A0 (fi) * 1989-04-07 1991-10-04 Pfizer Substituerade kromaner foer behandling av astma, ledgaongsinflammation och beslaektade sjukdomar.
WO1990015801A1 (en) * 1989-06-22 1990-12-27 Pfizer Inc. Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases
FI923546A0 (fi) * 1990-02-07 1992-08-06 Pfizer Tetralin- och kromanderivat anvaendbara vid vaord av astma, ledinflammation och motsvarande sjukdomar.
ES2098547T3 (es) * 1992-01-23 1997-05-01 Pfizer Benzopirano y otros antagonistas de ltb4 relacionados.
EP0558245A1 (en) * 1992-02-25 1993-09-01 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors
FR2693196B1 (fr) * 1992-07-03 1994-12-23 Lipha Dérivés de benzopyranone ou de benzothiopyranone, procédé de préparation et composition pharmaceutique les contenant.

Also Published As

Publication number Publication date
JP2765757B2 (ja) 1998-06-18
YU3393A (sh) 1996-07-24
CA2126752A1 (en) 1993-08-05
EP0623123B1 (en) 1997-04-23
JPH07502536A (ja) 1995-03-16
SK280451B6 (sk) 2000-02-14
ATE152108T1 (de) 1997-05-15
HUT68790A (en) 1995-07-28
GR3023657T3 (en) 1997-09-30
BG98867A (bg) 1995-03-31
NO942759L (no) 1994-07-22
CA2126752C (en) 2000-05-16
DE69219364D1 (de) 1997-05-28
ZA93486B (en) 1994-07-22
CN1075318A (zh) 1993-08-18
WO1993015067A1 (en) 1993-08-05
TW213907B (cs) 1993-10-01
DE69219364T2 (de) 1997-08-07
RU94035964A (ru) 1997-05-27
RU2114110C1 (ru) 1998-06-27
BG62331B1 (bg) 1999-08-31
EP0623123A1 (en) 1994-11-09
FI943474L (fi) 1994-07-22
AP9200449A0 (en) 1993-01-31
YU48949B (sh) 2003-01-31
BR9207061A (pt) 1995-12-26
SK84494A3 (en) 1995-05-10
CN1041311C (zh) 1998-12-23
IL104386A (en) 2001-05-20
US5552435A (en) 1996-09-03
RO112031B1 (ro) 1997-04-30
IS3969A (is) 1993-07-24
NZ245735A (en) 1995-04-27
PH30346A (en) 1997-04-02
MX9300312A (es) 1993-07-31
PT101183A (pt) 1994-03-31
US5684046A (en) 1997-11-04
NO942759D0 (no) 1994-07-22
HU9401979D0 (en) 1994-09-28
CZ282400B6 (cs) 1997-07-16
OA11456A (en) 2003-11-18
HU221194B1 (en) 2002-08-28
KR950700273A (ko) 1995-01-16
SG49813A1 (en) 1998-06-15
IL104386A0 (en) 1993-05-13
AP352A (en) 1994-08-10
MY109144A (en) 1996-12-31
IS1795B (is) 2001-12-18
PL171003B1 (pl) 1997-02-28
FI943474A7 (fi) 1994-07-22
AU666896B2 (en) 1996-02-29
KR0124802B1 (ko) 1997-11-25
AU3065092A (en) 1993-09-01
NO306508B1 (no) 1999-11-15
HK1000245A1 (en) 1998-02-13
FI943474A0 (fi) 1994-07-22
DK0623123T3 (da) 1997-10-13
PT101183B (pt) 1999-09-30
CZ176294A3 (en) 1995-02-15

Similar Documents

Publication Publication Date Title
IL104421A0 (en) Benzopyran and related ltb4 antagonists
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
EG20202A (en) Benzopyran and related LTB4 antagonists
IL115528A0 (en) Benzopyran and benzo-fused compounds
HU9303442D0 (en) Jodinated benzoyl-acetats and ketals
HU9500003D0 (en) Fungicidal 2-imidazoline-5-one and 2-imidazoline-5-thione derivatives
IL104472A0 (en) Substituted hexahydro-azepinones and tetrahydro-benzazepinones
PL309361A1 (en) Benzopyran derivatives
EP0505941A3 (en) Peptifluorin and neopeptifluorin
ZA93483B (en) Benzopyrans and related ltb antagonists
ZA899435B (en) Benzopyran and related compounds
IE883574L (en) Azoles and related intermediates
IL122653A0 (en) Benzopyrans and their preparation
IE901744L (en) Benzopyran and pyridopyran derivatives
ZA925260B (en) 3-aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone
IL125949A0 (en) Benzopyran and benzo-fused compounds and their preparation
GB9118954D0 (en) Construction components and their uses
ZA947921B (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof